Overview

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

Status:
Completed
Trial end date:
2016-10-28
Target enrollment:
Participant gender:
Summary
This study is intended to determine whether the addition of trospium chloride to xanomeline tartrate will ameliorate the peripheral cholinergic side effects that have been previously experienced with xanomeline tartrate when administered alone.
Phase:
Phase 1
Details
Lead Sponsor:
Karuna Pharmaceuticals
Karuna Therapeutics
Treatments:
Trospium chloride
Xanomeline